Split History
ETFs Holding BIOD »    BIOD Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Albireo Pharma is a biopharmaceutical company focused on the development and commercialization of treatments for diabetes. Co.'s primary product candidate is a glucagon emergency management (GEM) drug-device combination that is intended to treat diabetes patients experiencing severe hypoglycemia, or very low concentrations of blood glucose. In addition to its GEM product, Co. is developing ultra-rapid-acting proprietary insulin formulations that are designed to be more rapid-acting for Type 1 and Type 2 diabetes patients. Also, Co. has used its proprietary excipients to develop pre-clinical analog-based ultra-rapid-acting insulin formulations using either insulin lispro or insulin aspart. According to our BIOD split history records, BIOD has had 1 split.
BIOD split history picture
BIOD (BIOD) has 1 split in our BIOD split history database. The split for BIOD took place on June 12, 2012. This was a 1 for 4 reverse split, meaning for each 4 shares of BIOD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.

When a company such as BIOD conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the BIOD split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BIOD shares, starting with a $10,000 purchase of BIOD, presented on a split-history-adjusted basis factoring in the complete BIOD split history. BIOD split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/22/2007
End date: 11/03/2016
Start price/share: $66.84
End price/share: $0.65
Dividends collected/share: $0.00
Total return: -99.03%
Average Annual Total Return: -40.10%
Starting investment: $10,000.00
Ending investment: $97.21
Years: 9.04
Date Ratio
06/12/20121 for 4
BIOD is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BIOL Split History
BMRA Split History
BMY Split History
BOC Split History
BONE Split History
BOTA Split History
BRLI Split History
BSPM Split History
BSTC Split History
BSX Split History

Astrotech (ASTC)
CHF Solutions, Inc. (CHFS)
Tandem Diabetes Care, Inc (TNDM)
Alliqua BioMedical, Inc. (ALQA)
Soleno Therapeutics, Inc. (SLNO)
InfoSonics Corporation (IFON)
Bioblast Pharma Ltd. (ORPN)
Rennova Health, Inc. (RNVA)
Diana Containerships Inc. (DCIX)
Ocean Rig UDW Inc. (ORIG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BIOD Insider Buying

BIOD Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.